Recombinant
Human Growth Hormone (rhGH) Megestral
Acetate Produces Weight Gain, but Adding Testosterone Does Not Increase
Lean Body Mass 12/08/06
Pravastatin,
Rosiglitazone, and Growth Hormone Fail as Treatments for HIV-related Lipoatrophy
10/10/06
Recombinant
Human Growth Hormone (Serostim) for the Treatment of HIV-associated Adipose
Redistribution Syndrome - 8/18/06 Daily
Use of Recombinant Human Growth Hormone Increases HIV-specific T cell Responses
and Interferon-producing CD8 T Cell Responses in Patients on Antiretroviral Therapy
- 3/07/06 Serono
Completes Second Phase III Trial of Human Growth Hormone (Serostim) for
HIV-related Adipose Redistribution Syndrome - 1/17//06 TH-9507,
a Growth Hormone Releasing Factor Shows Early Promise as an Effective and
Safe Therapy for HIV-related Central Obesity - 8/03/05 Serono
Completes Clinical Milestone in Phase III Trial of Human Growth Hormone (Serostim)
for HIV-associated Adipose Redistribution Syndrome (HARS) - 6/17/05 Growth
Hormone-releasing Hormone Could Help Build Bone in HIV Patients
- 5/23/05 Serono
Completes Enrollment for Phase III Trial of Serostim for HIV-associated
Fat Redistribution
- 1/26/05 Low-Dose
Growth Hormone in HIV Positive Men with Fat Accumulation
Reduces
Total Body Fat and Increases Lean Body Mass - 09/03/04 Phase
III Trial of Human Growth Hormone for HIV-related Adipose Redistribution
Syndrome
- 06/02/04 Human
Growth Hormone (rhGH) Improves Lean Body Mass, Physical
Performance,
and Quality of Life in HIV Patients on HAART with HIV-related
Weight
Loss or Wasting 03/24/04
reatment
with Recombinant Human Growth Hormone (r-hGH) Decreases
Visceral
Adipose Tissue in HIV Patients with Fat Redistribution Syndrome 03/03/04
| |
